In recent discussions, prominent figures in the AI industry, including Sam Altman of OpenAI and Dario Amodei of Anthropic, have raised alarms about the risks associated with AI in the context of biological weapons. Their concern is not that AI will create bioweapons independently, but that advanced AI systems could empower individuals with malicious intent to develop dangerous biological agents by simplifying access to complex biological research. With the digitization of biology, including the availability of scientific literature and genetic databases online, the potential for AI to assist in navigating this information poses significant risks. The executives are advocating for mandatory screening of synthetic DNA and RNA orders, emphasizing the need for safeguards as synthetic biology becomes more accessible. This rare consensus among competing tech companies highlights the urgency of addressing these risks before they escalate into a crisis, as there is currently no evidence that public AI systems are involved in creating biological weapons.